Lifeworks Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.38M Buy
50,553
+3,900
+8% +$374K 0.56% 61
2025
Q4
$4.48M Sell
46,653
-10,836
-19% -$1.05M 0.58% 57
2025
Q3
$5.48M Buy
57,489
+54,820
+2,054% +$5.04M 0.73% 39
2025
Q2
$233K Buy
+2,669
New +$226K 0.03% 287
2022
Q3
Sell
-3,715
Closed -$333K 149
2022
Q2
$333K Buy
3,715
+862
+30% +$87.3K 0.21% 97
2022
Q1
$317K Buy
2,853
+175
+7% +$18.5K 0.21% 95
2021
Q4
$277K Buy
+2,678
New +$310K 0.22% 98

Other funds holding MDT

Lifeworks Advisors's MDT Position: Q1 2026 in Review

Lifeworks Advisors increased its Medtronic (MDT) stake by 8.4% in Q1 2026, buying an estimated $374K and bringing the position to 50,553 shares worth $4.38M. The position accounts for 0.56% of the portfolio, ranked #61.

Lifeworks Advisors first reported a position in MDT in Q4 2021 and has held it in 7 quarters since. The position peaked at $5.48M in Q3 2025. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Lifeworks Advisors held 50,553 shares of Medtronic worth $4.38M as of Q1 2026.
  • Lifeworks Advisors bought 3,900 Medtronic shares in Q1 2026, an estimated $374K.
  • Medtronic made up 0.56% of Lifeworks Advisors's portfolio in Q1 2026, its #61 holding.
  • Lifeworks Advisors first reported a position in Medtronic in Q4 2021 and has held it in 7 quarters since.
  • Lifeworks Advisors's Medtronic position peaked at $5.48M in Q3 2025.
  • 2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Lifeworks Advisors's 13F filing for Q1 2026, filed 4 May 2026.